Background Pediatric differentiated thyroid carcinoma (DTC) is a rare disease, although it is the most frequent endocrine malignancy in children, representing 2–4% of all pediatric malignancies. According to the Surveillance, Epidemiology, and
Search Results
S C Clement, W E Visser, C A Lebbink, D Albano, H L Claahsen-van der Grinten, A Czarniecka, R P Dias, M P Dierselhuis, I Dzivite-Krisane, R Elisei, A Garcia-Burillo, L Izatt, C Kanaka-Gantenbein, H Krude, L Lamartina, K Lorenz, M Luster, R Navardauskaitė, M Negre Busó, K Newbold, R P Peeters, G Pellegriti, A Piccardo, A L Priego, A Redlich, L de Sanctis, M Sobrinho-Simões, A S P van Trotsenburg, F A Verburg, M Vriens, T P Links, S F Ahmed, and H M van Santen
Alexander Heinzel, Dirk Müller, Hanneke M van Santen, Sarah C Clement, Arthur B Schneider, and Frederik A Verburg
-1375678 ) 13 Thies ED Tanase K Maeder U Luster M Buck AK Hanscheid H Reiners C Verburg FA . The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma
Keiko Ohkuwa, Kiminori Sugino, Mitsuji Nagahama, Wataru Kitagawa, Kenichi Matsuzu, Akifumi Suzuki, Chisato Tomoda, Kiyomi Hames, Junko Akaishi, Chie Masaki, and Koichi Ito
patients with DTC and is predominantly observed in the lungs and bone ( 3 , 4 , 5 , 6 ). When treating metastatic tumors of differentiated thyroid carcinoma, a favorable prognosis can be expected after radioactive iodine (RAI) therapy after total
Tiemo S Gerber, Arno Schad, Nils Hartmann, Erik Springer, Ulrich Zechner, and Thomas J Musholt
Introduction Poorly differentiated thyroid carcinoma (PDTC) represents an aggressive variant of thyroid cancer that predominantly arises from the differentiated variants of papillary and follicular thyroid carcinoma (PTC and FTC, respectively
Norra Kwong, Ellen Marqusee, Michael S Gordon, P Reed Larsen, Jeffrey R Garber, Matthew I Kim, and Erik K Alexander
2013 37 1599 – 1605 . ( doi:10.1007/s00268-013-2006-9 ). 23 Lee J Soh EY . Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors . Annals of Surgery 2010 251 114
Andrea Mazurat, Andrea Torroni, Jane Hendrickson-Rebizant, Harbinder Benning, Richard W Nason, and K Alok Pathak
Introduction Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers that are associated with increasing incidence and excellent posttreatment outcome (1) . This group comprises different histological types, the most
Maria Luisa Garo, Désirée Deandreis, Alfredo Campennì, Alexis Vrachimis, Petra Petranovic Ovcaricek, and Luca Giovanella
) 22 Tang J Kong D Cui Q Wang K Zhang D Liao X Gong Y & Wu G . Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes . World Journal of Surgical Oncology 2018 16 45 . ( https
Thera P Links, Trynke van der Boom, Wouter T Zandee, and Joop D Lefrandt
indicate that administration of TSH suppression therapy is associated with increased cardiovascular risk ( 36 , 37 ). Prevention of cardiovascular events in differentiated thyroid carcinoma The question arises which DTC patients are at risk of
Natalie Su-Jing Yap, Richard Maher, and Diana Louise Learoyd
Introduction Differentiated thyroid carcinoma (DTC) is the most common endocrine malignancy, of which the majority are papillary thyroid carcinoma (PTC). While prognosis is generally favourable, up to 20% of patients develop local or regional
Kim Magaly Pabst, Robert Seifert, Nader Hirmas, Martina Broecker-Preuss, Manuel Weber, Wolfgang Peter Fendler, Timo Bartel, Sarah Theurer, Ken Herrmann, and Rainer Görges
Current guidelines for differentiated thyroid carcinoma (DTC) ( 1 , 2 ) assign a crucial diagnostic importance to stimulated thyroglobulin (s-Tg) measurement 6–12 months after completion of primary therapy to predict a recurrence-free follow-up than in